Milvue vs Rayscape (2026)
Two European radiograph vendors covering both trauma and chest, close enough that the decision turns on delivery. Milvue returns a pre filled structured report to the reporting system within seconds across seven pathology families, with authorization in three jurisdictions and an explicit choice between secure cloud and on premise. Rayscape reads chest broadly with longitudinal comparison against prior scans, adds lung nodule work on computed tomography, and carries independent evaluation from a tuberculosis screening deployment, which is a harder test than a reader study. If the bottleneck is report turnaround, Milvue delivers a draft rather than a flag. If it is chest reading depth and change over time, Rayscape goes further.
- It returns a pre filled structured report to the reporting system in seconds across seven pathology families spanning trauma and chest.
- Authorization across three jurisdictions with clearly delineated scope, documented rather than implied.
- Deployment is an explicit choice between secure cloud and on premise, which is better disclosed than most peers manage.
- Chest coverage is broad with longitudinal comparison against a patient's prior scans, plus lung nodule work on computed tomography.
- Independent evaluation in a tuberculosis screening context is a harder test than a retrospective reader study.
- On premise and cloud are both offered, which matters where images cannot leave the institution.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Milvue and Rayscape are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Milvue | Rayscape |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2018 | 2019 |
| Headquarters | Paris, France | Timisoara, Romania |
| Website | milvue.com | rayscape.ai |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Milvue
-
Clinical evidence
A retrospective single-center study published in Diagnostics externally validated several CE-certified AI systems, including Milvue's TechCare Kids, for automated bone age assessment.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
French imaging AI company based in Paris whose Milvue Suite reads plain radiographs. TechCare Alert detects fractures, dislocations, joint effusions, pneumothorax and nodules; TechCare Metrics returns about 60 automated bone measurements, including lower limbs, EOS, bone age and Cobb angles; and TechCare Report pre-fills the radiology report, which the company labels as not a medical device, with results returned in under 30 seconds.
Source: AI Health Index, August 2026
Romanian imaging AI company based in Timisoara whose Rayscape CXR analyzes chest X-rays, detecting and localizing 148 findings across 17 clinical classes, including tuberculosis, with bone suppressed views, an automatic cardiothoracic ratio and a normal or abnormal flag for worklist prioritization, and whose lung CT product detects nodules and compares them against a patient's prior scans. Its tuberculosis detection was evaluated independently in a South African tuberculosis prevalence survey published in The Lancet Digital Health in 2024.
Source: AI Health Index, August 2026
Questions buyers ask
How do Milvue and Rayscape work with the EHR?
Milvue is also listed in the Blackford Analysis imaging AI portfolio, a named orchestration platform that gives a second route into an existing workflow.
Rayscape CXR integrates with the archive over DICOM, on premises or with a cloud archive, returning annotated images and structured outputs inside the native radiology viewer without a separate workspace, and sites can configure outputs, thresholds and visualization to their own reporting standards. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How are Milvue and Rayscape priced and sold?
In Milvue's case, the module structure is public, though. TechCare Alert handles detection, TechCare Metrics handles measurements and TechCare Report produces the prefilled report, and the three carry different regulatory status.
The company's site has a pricing and plans page, and its AWS Marketplace listing for Rayscape CXR shows a free subscription with no end date alongside a 30 day money back guarantee on the current annual term, which suggests a paid annual contract behind the listing without stating its price or unit. The product can be procured through the marketplace and directly. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
How do Milvue and Rayscape handle patient data?
With Milvue, the TechCare Trauma 510(k) summary (K242171) states that the software is deployed on premises or in the cloud; a hospital that runs it on premises keeps its studies inside its own systems, which removes most of the retention and secondary use question for that site.
In Rayscape's case, the company's AWS Marketplace listing describes the product as software as a service, which sits uneasily with data never leaving the institution, and nothing says which deployments the commitment covers. Support, diagnostic and incident access usually carries exceptions. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Which settings and specialties do Milvue and Rayscape cover?
For Milvue, the home page's "fracture detection validated with no age limit" matches the cleared indication from birth.
With Rayscape, the tuberculosis use has independent validation in a South African prevalence survey (The Lancet Digital Health, 2024), a population screening setting; the broader findings set and the CT product have no published per finding validation. The company reports clinical use at more than 300 sites in 18 countries, and its customer stories describe emergency and outpatient deployments. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified August 4, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both publish headline performance figures that are not comparable across vendors, since each defines findings and reference standards differently, so ask for performance on the findings your population actually presents with. Neither publishes an independent security attestation. Milvue's clearance reader study spans physicians of differing expertise, which is more subgroup information than most vendors provide, though it addresses reader variation rather than patient variation. Prevalence determines the false positive burden more than sensitivity does.